newsfilter
← Latest News
GlobeNewswire·

Strongbridge Biopharma plc Provides Corporate Update

~ Company Reported Positive and Statistically Significant Top-Line Results from the Pivotal Phase 3 LOGICS Study of RECORLEV® (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome; To...